Severe Group A Streptococcus Infections in Paris, France, 2018-2023

CompletedOBSERVATIONAL
Enrollment

269

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

August 19, 2024

Study Completion Date

August 19, 2024

Conditions
Invasive Group A Beta-Haemolytic Streptococcal Disease
Interventions
OTHER

Collection of data from the patient's medical file

Collection of data from the patient's medical file (electronic health record). The identification of eligible cases will be conducted through an examination of the hospital's electronic microbiology database. Subsequently, the complete hospital record(s) of each patient will be used to extract a pre-defined set of variables required for data analysis.

Trial Locations (1)

75015

Hôpital Necker-Enfants Malades, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06297122 - Severe Group A Streptococcus Infections in Paris, France, 2018-2023 | Biotech Hunter | Biotech Hunter